AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05477485 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: No Intervention/Usual care
Description: Participants in the usual care arm will receive standard state-level care for late ART prescription refill(s) for Virginia Medicaid enrollees living with HIV.
Study NCT05642260 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: fall prevention programe
Description: Patients in the experimental group will receive a comprehensive fall prevention program (guided by the post-TKR protocol followed at Al-Razi Orthopedic Hospital) into the conventional physiotherapy treatment
Study NCT05970588 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standing Promotion Intervention
Description: Participants will be provided with a standing desk converter to set on top of their existing desk for 4 weeks.
Study NCT04569747 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Pertuzumab+TRASTUZUMAB
Description: Trastuzumab + pertuzumab SC FDC (PHESGO) will be administered on Day 1 of each 21-day cycle , subcutaneous, fixed dose
Study NCT04569747 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ADJUVANT ENDOCRINE THERAPY
Description: Oral, daily per cycle
Study NCT05496413 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: STARSTIM
Description: In order to evaluate the working memory ability of schizophrenic participants, a task was designed that needs to be performed by them. Firstly, a stimulus of six different color circles of same size in a gray background would be given for 500ms. This would be followed by 2000ms delay phase and then a test array would be appeared. The test array would be exactly same to the stimulus array but with or without change in color of only one circle. The test array would appear on the screen till the participants record their response and they would be asked to respond if the test array matches to the stimulus or not.
Study NCT05496413 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: STARSTIM
Description: In order to evaluate the working memory ability of schizophrenic participants, a task was designed that needs to be performed by them. Firstly, a stimulus of six different color circles of same size in a gray background would be given for 500ms. This would be followed by 2000ms delay phase and then a test array would be appeared. The test array would be exactly same to the stimulus array but with or without change in color of only one circle. The test array would appear on the screen till the participants record their response and they would be asked to respond if the test array matches to the stimulus or not.
Study NCT04950049 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diluted dexamethasone 10ml
Description: receive 10ml dexamethasone (1mg/ml) diluted with 5% glucose
Study NCT04950049 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diluted dexamethasone 20ml
Description: receive 20ml dexamethasone (0.5mg/ml) diluted with 5% glucose
Study NCT06453161 — intervention group
Intervention type: OTHER
Intervention: Post-operative acute kidney injury
Description: Serum creatinine increase by 0.3 mg/dl within 48 h OR Serum creatinine ≥ 1.5-1.9 times baseline within 7 days~Baseline creatinine is defined as the last pre-operative value available in the medical file
Study NCT05117554 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: casdatifan
Description: Capsule
Study NCT05102656 — intervention group
Intervention type: OTHER
Intervention: Best Practice
Description: Physician conversations occur in-person
Study NCT05102656 — intervention group
Intervention type: PROCEDURE
Intervention: Discussion
Description: Physician conversations occur via video call
Study NCT05102656 — intervention group
Intervention type: OTHER
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT05532618 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Adductor canal block
Description: Before anterior cruciate ligament surgery an adductor canal block will be placed using ultrasound.
Study NCT05532618 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Adductor canal block
Description: Before anterior cruciate ligament surgery an adductor canal block will be placed using ultrasound.
Study NCT05532618 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levobupivacaine
Description: Levobupivacaine
Study NCT05532618 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 10 ml of sodium chloride 0.9%
Study NCT06045871 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Corticotomy followed by compression osteogenesis
Description: Surgical corticotomy supra apical in anterior maxilla then application of the compression osteogenesis concept via traction on miniscrews implanted above the corticotomy line
Study NCT06445361 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: FibroScan
Description: Performance of a FibroScan measurement to determine steatosis and fibrosis.
Study NCT04658771 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MR-HIFU treatment
Description: MR-HIFU is an innovative technology that allows for non-invasive thermal ablation of tissues and tumors by integrating an external high intensity focused ultrasound (HIFU) transducer with a conventional MRI scanner.~The focused ultrasound transducer is placed outside of the body and generates and focuses acoustic energy to heat tumors or other pre-defined focal regions of tissues inside the body. Because the acoustic energy is precisely focused over tiny areas of tissue, potential thermal injury to surrounding tissues is minimal. Cell death inside the selected treatment area occurs via coagulative necrosis while avoiding injury to intervening and adjacent tissues.
Study NCT05117554 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Capsule
Study NCT05117554 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: Syrup solution
Study NCT03896711 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MEMORI Corps program
Description: Activity-based companion care program. Delivered by trained senior volunteers, supported by a clinical team, over a 12-week intervention period (8 hours per week, 2 or 3 days per week) for each person with dementia/family caregiver dyad. Primary roles of the volunteers are to provide in-home supervision, peer-to-peer companionship, and a evidence-based individualized activity program that focuses on meaningful, engaging and enjoyable activities that match PWD abilities and interests.
Study NCT03896711 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Augmented Waitlist Control
Description: Persons with dementia/caregivers will continue any services and supports being used, will receive a free copy of A Caregiver's Guide to Dementia: Using Activities and Other Strategies to Prevent, Reduce and Manage Behavioral Symptom103), written educational materials on management of CG stress/well-being, and bi-weekly check-in calls to answer any questions about the materials. Volunteers randomized to waitlist control will continue with usual activities (volunteer or other), and will receive additional written educational materials on cognitive health (NIA) and exercise and Physical Activity (Go4Life), referrals to the Baltimore City Commission on Aging and Retirement Education for volunteering opportunities, and bi-monthly check-in calls to answer questions and maintain engagement. Waitlist dyads will be followed at specified intervals by the research team and then offered an opportunity for participation in the intervention arm.
Study NCT06035861 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XBD173
Description: Participants will be treated with XBD173 90mg twice daily for 6 weeks
Study NCT04887935 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Description: -The 10 mg dose is reflective of current clinical practice for diabetes and heart failure
Study NCT05995431 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: scaling and root planing
Description: All the participants will undergo scaling and root planing
Study NCT05995431 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Subgingival instrumentation
Description: All the participants will undergo subgingival instrumentation
Study NCT05281003 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Biological: Pembrolizumab 200 mg administered IV Q3W on Day 1 of each 3-week cycle, up to 4 administrations in neoadjuvant setting.
Study NCT05281003 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Drug: Paclitaxel 150 mg/m\^2 administered IV Q3W on Day 1 of each 3-week cycle, up to 4 administrations in neoadjuvant setting.
Study NCT05281003 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Drug: Cisplatin 80 mg/m\^2 administered IV Q3W on Day 1 of each 3-week cycle, up to 4 administrations in neoadjuvant setting.
Study NCT06528535 — intervention group
Intervention type: OTHER
Intervention: Health promotion intervention
Description: Health promotion activities on nutrition with distribution of baskets of fresh fruits and vegetables
Study NCT05245721 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nalbuphine
Description: Caudal nalbuphine injection in pediatrics undergoing infra-umbilical surgeries
Study NCT05245721 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacain
Description: Caudal bupivacaine in pediatrics undergoing infra-umbilical surgeries
Study NCT05550987 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rehabilitation program with the use of mechanical vibration using the Vibramoov device and conventional physiotherapy
Description: The Vibramoov device (Techno Concept, France) will be used in the rehabilitation program. Before starting the training session, each subject will undergo a diagnosis in order to qualify for the use of Functional Proprioceptive Vibration. Before starting the therapy, pads are placed on the patient's body to fix the vibrating modules in the places to be treated (lower limbs, left upper limb or right upper limb). Then the vibrating modules are attached to the supports. The therapy carried out with the use of the Vibramoov device consists in the targeted and individualized stimulation of the nervous system, as in the course of natural movements of the upper or lower limbs with the use of visual biofeedback. Therapy with the use of the Vibramoov device will be carried out 4 times a week for 50 minutes a day. Additionally, individual physiotherapy (50 minutes) and upright standing (50 minutes) will be conducted 5 times a week.
Study NCT05550987 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rehabilitation program with gait training using the Ekso GT exoskeleton and conventional physiotherapy
Description: The Ekso GT ™ exoskeleton (Ekso Bionics, Inc. Richmond, CA, USA) used in the rehabilitation program has been approved by the Food and Drug Administration (FDA). Before starting the training session, each subject will undergo a thorough diagnosis to individually adjust the bionic skeleton. After entering the patient's data into the device's software, the physiotherapist selects the optimal training parameters. As the patient progresses during the training unit, the therapist will update the exoskeleton settings on an ongoing basis, so that the training is best suited to the current capabilities of the subject. Therapy with the use of the exoskeleton device will be carried out 4 times a week for 50 minutes a day. Additionally, individual physiotherapy (50 minutes) and upright standing (50 minutes) will be conducted 5 times a week.
Study NCT05550987 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rehabilitation program with the use of gait training with the use of a RoboGait stationary robot and conventional physiotherapy.
Description: The RoboGait stationary robot (Bama technologist, Turkey) will be used in the rehabilitation program. Before starting the training session, each subject will undergo detailed diagnostics in order to individually adjust the orthoses. The next step will be to put on a vest and inguinal straps on a wheelchair or standing, and then lift it up with the device, then attach it to the Robogait orthoses. After entering the patient's data into the software of the device, the physiotherapist selects the optimal training parameters. During the session, biofeedback is also displayed informing the patient and the therapist about the patient's activity level in the transfer phase and the support during walking for both lower limbs. Therapy with the use of the RoboGait device will be carried out 4 times a week for 50 minutes a day. Additionally, individual physiotherapy (50 minutes) and upright standing (50 minutes) will be conducted 5 times a week.
Study NCT05550987 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rehabilitation program with the use of gait training with the use of the ZEBRIS treadmill and conventional physiotherapy
Description: The Zebris FDM-T treadmill will be used in the rehabilitation program for gait analysis. Before each session, patients will be equipped with a harness for safety reasons. The need for a handrail will be assessed prior to each session and patients will be encouraged to support their hands as little as possible. Before starting the training session, each subject will undergo a thorough diagnosis in order to individually adjust the training parameters. Therapy with the use of the Zebris FDM-T treadmill will be carried out 4 times a week for 50 minutes a day. Additionally, individual physiotherapy (50 minutes) and upright standing (50 minutes) will be conducted 5 times a week.
Study NCT05550987 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rehabilitation program with the use of upper limb function training with the use of the PABLO device and conventional physiotherapy
Description: The Pablo (Tyromotion) device will be used in the rehabilitation program. Before the start of the training session, each subject will undergo detailed diagnostics assessing the range of mobility in the shoulder, radiocarpal (frontal and sagittal plane), elbow (sagittal plane), and explosive strength of the cylindrical, pinch and lateral and three-point grip. The Force Control Index will also be designated. The next stage will be training on the Pablo device using visual and auditory biofeedback. The physiotherapist selects the optimal training parameters (type of pad, type of game, level of the game). Each training session will be stored in the software and recorded in the patient's medical records. Therapy with the use of the Pablo device will be carried out 4 times a week for 50 minutes a day. Additionally, individual physiotherapy (50 minutes) and upright standing (50 minutes) will be conducted 5 times a week.
Study NCT05550987 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control Group
Description: In control Group the rehabilitation program will be carried out for a period of 4 weeks. In each of the studied groups, the rehabilitation program will include conventional physiotherapy sessions performed 5 times a week, consisting of 50 minutes a day of individual physiotherapy and 50 minutes a day of standing upright.
Study NCT05913206 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Ambiguity
Description: The intervention is a novel communication approach to communicate ambiguity related to the potential risks and benefits associated with clinical decision making for parents and caregivers of children with medical complexity.
Study NCT05744791 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active Play planned movement program
Description: Teachers will implement an addition two physical activity opportunities that incorporate active play each day for a potential dose of 20-30 minutes per day and 100-150 minutes per week.
Study NCT05424211 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Music Therapy Mobile Application
Description: The authorities determined by taking consultancy from TÜMATA (Turkish Music Research and Promotion Group) will be uploaded to the mobile application developed by the software specialist. The maqams (Rast, Nihavent and Neva) to be used in the application will be played to the patients 3 times in half an hour at different times of the day via the mobile application. Rast tonality will be played in the morning, nihavent tune will be played at noon and neva tune will be played in the afternoon.
Study NCT04780217 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: T3011
Description: T3011 will be administered through IV drip or pumping.
Study NCT04809792 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: SBRT on the MR-Linac
Description: Radiotherapy is performed on the 1.5 T MR Linac
Study NCT05527730 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Comparison of PRO-FIT or SELF-FIT fitting
Description: add
Study NCT05527730 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Comparison of PRO-FIT or SELF-FIT fitting
Description: add
Study NCT06489093 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NSF
Description: Prior to treatment the working field is isolated with cotton rolls. Gingival barrier is used for soft tissue protection. Application of NSF using a microapplicator on the carious lesion for 1 minute. Excess material and gingival barrier are removed. Participants receive oral hygiene instructions.
Study NCT06489093 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SDF+KI
Description: Prior to treatment the working field is isolated with cotton rolls. Gingival barrier is used for soft tissue protection. Application of 38% silver diamine fluoride (Riva star 38%, SDI) using a microapplicator on the carious lesion. Immediately afterwards, potassium iodide is applied as a reducing agent. Excess material and gingival barrier are removed. Participants receive oral hygiene instructions.
Study NCT06489093 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control group
Description: Subjects will receive oral hygiene instructioins to apply fluoridated toothpaste to a toothbrush and brush teeth thoroughly for at least 2 minutes, then expectorate and rinse.
Study NCT05849532 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Functional Electrical Stimulation
Description: 12-weeks of training sessions that include initial screening and clinical assessment (Week 1-2), onsite training sessions (Week 3-4), home training sessions (Week 4-8). There will also be pre (Week 1), mid (Week 7) and post-training (Week 12) assessment. Each session will consist of a 10-minute warm-up session with 5-6 stretching exercises. Warm-up will be followed by a 30 minute training session comprising of mobility, balance and walking exercises with FES. This will be followed by a cool down session for 10-minutes comprising of 5-6 muscle stretches. The participant will first watch video of the each exercise on the android tablet and then perform the exercises.
Study NCT01433393 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-875
Study NCT01433393 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT05232435 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pilate mat exercise will be performed
Description: pilate group:1- bridging 2- shoulder bridge 3- front support 4- spine stretch forward 5- spine twist plus standard treatment(stretch hamstring -stretch lower back - strength abdominal muscles - electrical heat pad)
Study NCT05232435 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MET
Description: Will receive MET for hamstring and erectorspinae plus standard treatment
Study NCT05232435 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: control group receive standard treatment
Description: electrical heat pad - stretch hamstring - stretch lower back muscles - stregth abdominal muscles
Study NCT06059534 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Dietary supplementation with placebo.
Description: Volunteers will be provided with the placebo capsules. For each volunteer, different age-associated skin parameters will be measured with specialized equipment before the treatment and 4, 8 and 12 weeks after the first oral intake of the product.
Study NCT06059534 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dietary supplementation with DracoBelleTM Nu.
Description: Volunteers will be provided with the DracoBelleTM Nu capsules. For each volunteer, different age-associated skin parameters will be measured with specialized equipment before the treatment and 4, 8 and 12 weeks after the first oral intake of the product.
Study NCT05016037 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Lexically based speech recast
Description: a child's spontaneous or elicited production containing phonological errors is immediately followed with a clinician model that corrects the error(s) at the word level rather than the isolated phoneme level. As an example, a speech recast of child's production of the word bake as \[be\] would be the whole lexeme bake \[bek\] rather than production drill on \[k\] in isolation.
Study NCT05158881 — intervention group
Intervention type: DEVICE
Intervention: Near-infrared spectroscopy
Description: Near-infrared spectroscopy (NIRS) offers the non-invasive continuous monitoring of cerebral oxygenation and perfusion. Cerebral regional oxygen (crSO2) measured via NIRS represents a mixed tissue saturation value, thus enabling information on the balance of cerebral oxygen delivery and oxygen consumption.
Study NCT04912596 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Albuterol Sulfate inhalation aerosol 108 mcg per actuation
Description: equal to albuterol 90 mcg/puff, MDI
Study NCT04912596 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Proair HFA (Albuterol Sulfate) or FDA authorized generic: Albuterol Sulfate HFA (Teva Pharmaceutical USA, Inc.) Inhalation Aerosol 108 mcg per actuation
Description: equal to albuterol 90 mcg/puff, MDI
Study NCT04912596 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Proair HFA or FDA authorized generic: Albuterol Sulfate HFA Inhalation Placebo
Description: MDI
Study NCT04912596 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Proair HFA or FDA authorized generic: Albuterol Sulfate HFA Inhalation Placebo
Description: MDI